Healthcare · Diagnostics Research · NASDAQ
| Market cap | $37.37B |
|---|---|
| Trailing P/E | 48.0 |
| FCF yield | 2.4% |
| Revenue growth (YoY) | -0.7% |
| EPS growth (YoY) | +98.0% |
| FCF/share growth (YoY) | +33.8% |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics Research |
Illumina, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Mar 9, 2026 |
| Lisa McClain | House | Sell | $1,001 - $15,000 | Nov 21, 2025 |
| Lisa McClain | House | Sell | $1,001 - $15,000 | Nov 21, 2025 |
| Lisa McClain | House | Buy | $1,001 - $15,000 | Aug 13, 2025 |
| Thomas H. Kean | House | Buy | $1,001 - $15,000 | May 15, 2025 |
| Michael C. Burgess | House | Sell | $15,001 - $50,000 | Oct 1, 2024 |
| Michael C. Burgess | House | Sell | $15,001 - $50,000 | Sep 24, 2024 |
| Thomas H. Kean | House | Buy | $1,001 - $15,000 | May 30, 2024 |
| Michael C. Burgess | House | Sell | $1,001 - $15,000 | Apr 10, 2024 |
| Michael C. Burgess | House | Sell | $1,001 - $15,000 | Mar 22, 2024 |
| Michael C. Burgess | House | Buy | $15,001 - $50,000 | Mar 7, 2024 |
| Michael C. Burgess | House | Sell | $1,001 - $15,000 | Mar 7, 2024 |